HOME >> MEDICINE >> NEWS
Wavefront LASIK advances refractive surgery

nt wavefront LASIK systems have been approved by the FDA. Alcon's LADARWave Customized Ablation system was approved in October 2002, the VISX Custom Vue system was approved in May of this year and Bausch & Lomb's Zyoptix system recently received preliminary approval by the FDA's Advisory Panel.

Studies comparing results of wavefront LASIK with conventional LASIK found that 90 to 94 percent of patients receiving wavefront LASIK achieved visual acuity of 20/20 or better, whereas up to 80 percent of those receiving conventional LASIK achieved 20/20 or better.

However, wavefront LASIK may not be for everyone. Because wavefront LASIK removes more corneal tissue than conventional LASIK, patients with thin corneas may not be good candidates. Patients with high degrees of aberration, severely dry eyes, or conditions that affect the lens or vitreous fluid inside the eye also may not be good candidates. However, these patients may still be good candidates for conventional LASIK.

Academy spokesperson Daniel Durrie, MD, of Durrie Vision in Overland Park, Kan., said, "It is important that patients get a thorough eye examination by a reputable eye surgeon before undergoing any surgery. They need to understand the potential risks as well as benefits of the procedure."

In addition to refractive surgery, wavefront technology is also being used in the design of contact and intraocular lenses and to diagnose retinal conditions.


'"/>

Contact: Media Relations
media@aao.org
415-561-8534
American Academy of Ophthalmology
2-Oct-2003


Page: 1 2

Related medicine news :

1. Wavefront LASIK demonstrated superior to conventional LASIK
2. Wavefront-guided LASIK improves contrast sensitivity
3. Temperature and humidity can affect LASIK surgery results
4. People with large pupils can now get LASIK and avoid night vision disturbances
5. Having dry eye before LASIK surgery is a risk factor for severe dry eye after surgery
6. Impact of scientific advances on drug studies and membrane research to be explored
7. Ending racial disparities in health care could save 5 times more lives than tech advances
8. Book celebrates centenary of citys advances in public health
9. New scientific advances in gastroenterology
10. Scientists detail latest advances in development of prosthetic devices for paralyzed
11. Latest advances in end-of-life care to be featured at Tampa conference

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the Congressional ... passed the U.S. House on May 4, would result in 23 million Americans losing ... implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , “It ...
(Date:5/26/2017)... ... 26, 2017 , ... Rob Lowe acts as host and helps educate and ... on hiking in American. Viewers can reconnect with America as it explores some of ... Many consumers have looked for an inventive new place for a family vacation, and ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Center CEO Mary Ellen, hospital employees, and town officials to celebrate the grand ... facility was developed by Rendina as part of its ongoing relationship with RWJBarnabas ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... and interpretation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance ... scalable and secure cloud platform for medical image management. At the core is ...
Breaking Medicine News(10 mins):
(Date:5/24/2017)... May 24, 2017  ivWatch LLC today announced ... (OEM) Board to enable seamless integration of ivWatch,s ... systems, infusion pumps and other devices. By integrating ... able to help health care customers deliver a ... related to IV therapy. "The ivWatch ...
(Date:5/18/2017)... , May 17, 2017  Bayer announced today that ... will be presented at the 53 rd Annual ... taking place June 2-6 in Chicago ... ASCO span prostate, colorectal, liver and thyroid cancers, as ... the Phase II CHRONOS-1 trial of copanlisib in patients ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology:
Cached News: